300204 Staidson

Watchlist

6.22
-0.09-1.43%

Trading Sep 10 13:36 CST

2.97BMarket Cap-11938P/E (TTM)

About Staidson Company

The company was founded in August 2002 and listed on the Shenzhen Stock Exchange GEM on April 15, 2011. The company's main business is R&D, production and marketing of innovative drugs, especially biopharmaceuticals, with independent intellectual property rights. The company's main products are the innovative biological drug threeptiscene (mouse nerve growth factor for injection) and the specialty product sultaiqing (compound polyethylene glycol electrolyte powder (IV)). The company received honors such as the Beijing Economic and Technological Development Zone's top 50 tax payment growth enterprises in 2011, high-tech enterprises in Beijing, innovative pilot enterprises in the Zhongguancun National Independent Innovation Demonstration Zone, and the third prize of the Beijing Science and Technology Progress Award.

Company Profile

Short Name-A舒泰神

Symbol-A300204

Company NameStaidson (Beijing) Biopharmaceuticals Co., Ltd.

Listing DateApr 15, 2011

Issue Price52.50

Shares Offered16.70M share(s)

FoundedAug 16, 2002

Legal Representativezhiwen zhou

General Managerchao wang

Secretarymaorong yu

Accounting FirmTianheng Certified Public Accountants (Special General Partnership)

Securities Representativehan cai

Legal CounselBeijing Kangda Law Firm

Employees512

Phone010-67875255

Office AddressNo. 36, Jinghai 2nd Road, Beijing Economic and Technological Development Zone, Beijing

Zip Code100176

Registered AddressNo. 36, Jinghai 2nd Road, Beijing Economic and Technological Development Zone, Beijing

Fax010-67875255

Emailsecurities@staidson.com

Websitehttp://www.staidson.com

Business License110302004270284

BusinessProduction of tablets, hard capsules, powders, oral solutions, and therapeutic biological products (pharmaceutical production license is valid until December 7, 2025); technology development, technology transfer, technical consulting, technical services for pharmaceuticals and biological products; import and export of goods, agency import and export, technology import and export. (Market players independently select business projects and carry out business activities in accordance with the law; projects subject to approval according to law carry out business activities according to the approved content after approval by the relevant departments; they are not allowed to engage in business activities for projects prohibited or restricted by national and local industrial policies.)

Company Executives

Name
Position
Salary

zhiwen zhou
Chairman, Directors, Chairman of the Strategy Committee
1.30M

rongqin zhang
Directors, Member of the Strategy Committee, Member of the Remuneration and Assessment Committee
1.70M

lianchun yang
Directors, Member of the Strategy Committee, Nomination Committee Members, Audit Committee Member
1.60M

xiaoyan wang
Directors
--

qishun lu
Independent Directors, Nomination Committee Members, Chairman of the Audit Committee
--

li zhao
Independent Directors, Member of the Strategy Committee, Chairman of the Remuneration and Assessment Committee, Audit Committee Member
136.80K

jiajun zhao
Independent Directors, Chairman of the Nomination Committee, Member of the Strategy Committee, Member of the Remuneration and Assessment Committee
136.80K

maorong yu
Board Secretary, Deputy General Manager
733.50K

han cai
Securities Affairs Representative
--

hongshan zhang
Chairman of the Supervisory Board, Auditors
900.00K

tao li
Auditors
600.00K

chao wang
General Manager, Head of Finance
1.36M

shicheng li
Chief Financial Officer
980.10K

yujing feng
Director of Internal Audit
477.00K

yanfang sun
Chief Engineer
272.00K

hong zheng
Employee Supervisors
588.10K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall